- Grand Venture Technology (SGX:JLB)'s 1H22 revenue increased to $67.1m (+6.9% h-o-h, +25.3% y-o-y), in line with expectations. Although 1H22 revenue makes up 46.1% of our full year forecasts, we note that this is due to seasonality where first half is usually weaker.
- - Read this at SGinvestors.io -
- Life sciences: Growth in the life sciences segment was brought about by higher wallet share from new customers and higher production volumes for mass spectrometers and its related products. Customer supply chain constraints continue to dampen the growth of the life sciences segment.
- - Read this at SGinvestors.io -
Our Thoughts on Grand Venture Tech's 1H22
Further advancements into the semiconductor front end to mitigate back-end semiconductor customer weakness.
- Read more at SGinvestors.io.
Above is the excerpt from report by DBS Group Research.
Clients of DBS may access the full report in PDF @ https://www.dbs.com/insightsdirect/.
Lee Keng LING DBS Group Research | Singapore Research Team DBS Research | https://www.dbs.com/insightsdirect/ 2022-08-12
Read also DBS's most recent report:
2024-02-27 Grand Venture Technology - Delayed But Not Derailed.
Previous report by DBS:
2023-11-17 Grand Venture Technology - Merit In Diversification.
Price targets by other brokers at Grand Venture Target Prices.
Listing of research reports at Grand Venture Analyst Reports.
Relevant links:
Grand Venture Share Price History,
Grand Venture Announcements,
Grand Venture Dividends & Corporate Actions,
Grand Venture News Articles